K.A. Bennett - Concepedia

Author

K.A. Bennett

Heptares Therapeutics (United Kingdom)ORCID

Also Known As

K. Bennett, K.A. Bennett, Kenden Bennett, Kirstie A Bennett, Kirstie A. Bennett, Kirstie Bennett

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Heptares Therapeutics (United Kingdom)MRC Laboratory of Molecular Biology University of Glasgow

About

K.A. Bennett is an author at Heptares Therapeutics (United Kingdom) specializing in medicine, signal transduction, and molecular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	2.3K
2	Biochemistry	4	4	1.9K
3	Natural Sciences	2	2	530
4	Cell Biology	1	1	270
5	Cellular Physiology	1	1	270

K.A. Bennett

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation Guillaume Lebon, Tony Warne, Patricia C. Edwards, Nature Molecular PharmacologySignal TransductionMolecular PhysiologyBiochemistryCommon Features	2011	871
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine A.S. Dore, N.J. Robertson, James C. Errey, Structure Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryG Protein-coupled Receptor	2011	546
Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain A.S. Dore, Krzysztof Okrasa, Jayesh C. Patel, Nature Molecular PharmacologySignal TransductionMolecular PhysiologyBiochemistryG Protein-coupled Receptor	2014	407
Intracellular allosteric antagonism of the CCR9 receptor Christine Oswald, Mathieu Rappas, James Kean, Nature InflammationSignal TransductionG Protein-coupled ReceptorImmunologyReceptor (Biochemistry)	2016	270
Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu <sub>5</sub> Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile) J.A. Christopher, Sarah J. Aves, K.A. Bennett, Journal of Medicinal Chemistry	2015	156
Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor Guillaume Lebon, K.A. Bennett, Ali Jazayeri, Journal of Molecular Biology Agonist AdenosineProtein AssemblyMolecular BiologyChemical BiologyAgonist-bound Conformation	2011	123
From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease Alastair Brown, Sophie J. Bradley, Fiona H. Marshall, Cell Molecular PharmacologyNeurodegenerative DiseasesAlzheimer's DiseaseMedicineMechanism Of Action	2021	87
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis Mathieu Rappas, A. Ali, K.A. Bennett, Journal of Medicinal Chemistry	2019	75
Pharmacology and Structure of Isolated Conformations of the Adenosine A2A Receptor Define Ligand Efficacy K.A. Bennett, Benjamin G. Tehan, Guillaume Lebon, Molecular Pharmacology	2013	73
Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein Gαo1 by the Ghrelin Receptor K.A. Bennett, Christopher J. Langmead, Alan Wise, Molecular Pharmacology	2009	37

Page 1